# A Study of Zomacton in Children With Growth Hormone Deficiency

> **NCT00884000** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 165 (actual)

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **DRUG:** Genotropin
- **DRUG:** Zomacton

## Key facts

- **NCT ID:** NCT00884000
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-07
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2012-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00884000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00884000, "A Study of Zomacton in Children With Growth Hormone Deficiency". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00884000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*